CVS Group (LON:CVSG) Given New GBX 1,400 Price Target at Jefferies Financial Group

CVS Group (LON:CVSG) had its price target boosted by Jefferies Financial Group from GBX 1,350 to GBX 1,400 in a research note released on Friday,Digital Look reports. Jefferies Financial Group currently has a hold rating on the stock.

CVSG has been the topic of several other research reports. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a research report on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,700 target price on shares of CVS Group in a report on Monday, July 27th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of GBX 1,720.

CVS Group Stock Up 0.2%

CVS Group stock opened at GBX 1,253 on Friday. CVS Group has a fifty-two week low of GBX 1,062 and a fifty-two week high of GBX 1,648. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. The firm’s 50-day simple moving average is GBX 1,229.71 and its 200 day simple moving average is GBX 1,244.92. The stock has a market cap of £867.08 million, a PE ratio of 18.19, a price-to-earnings-growth ratio of 1.77 and a beta of 1.06.

CVS Group declared that its Board of Directors has authorized a share buyback program on Tuesday, May 26th that authorizes the company to repurchase 0 outstanding shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In related news, insider Scott Morrison acquired 987 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The stock was acquired at an average price of GBX 1,270 per share, for a total transaction of £12,534.90. Insiders own 1.43% of the company’s stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.